Home LiteratureArticle Details
PMID: 12454777 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Induction of vasculogenesis in breast cancer models.

British journal of cancer ·Vol. 87 ·No. 12 ·2002-12-02 ·Pages 1454-61

Shirakawa K, Furuhata S, Watanabe I, Hayase H, Shimizu A, Ikarashi Y, Yoshida T, Terada M, Hashimoto D, Wakasugi H

Abstract

Recently, there have been reports of postnatal vasculogenesis in cases of ischaemia models. The aim of the present study is to provide evidence of postnatal vasculogenesis in breast-cancer-bearing mice. Based on cell surface antigen expression, we isolated endothelial precursor cells from bone marrow, peripheral blood and tumour-infiltrating cells from mice that had received six human breast cancer xenografts. In all three areas (bone marrow, peripheral blood and tumour-infiltrating cells), endothelial precursor cell population was elevated in all transplanted mice. Differentiation and migration activities of endothelial precursor cells were measured by comparing levels of the endothelial precursor cell maturation markers Flk-1, Flt-1, Tie2, VE-cadherin and CD31 among these three areas. The endothelial precursor cell population was 14% or greater in the gated lymphocyte-size fraction of the inflammatory breast cancer xenograft named WIBC-9, which exhibits a hypervascular structure and de novo formation of vascular channels, namely vasculogenic mimicry (Shirakawa et al, 2001). In vitro, bone marrow-derived endothelial precursor cells from four human breast cancer xenografts proliferated and formed multiple clusters of spindle-shaped attaching cells on a vitronectin-coated dish. The attaching cells, which incorporated DiI-labelled acetylated low-density lipoprotein (DiI-acLDL) and were negative for Mac-1. The putative bone marrow derived endothelial precursor cell subset, which was double positive of CD34 and Flk-1, and comparative bone marrow derived CD34 positive with Flk-1 negative subset were cultured. The former subset incorporated DiI-acLDL and were integrated with HUVECs. Furthermore, they demonstrated significantly higher levels of murine vascular endothelial growth factor and interleukin-8 in culture supernatant on time course by enzyme-linked immunosorbent assay. These findings constitute direct evidence that breast cancer induces postnatal vasculogenesis in vivo.

MeSH Terms
Animals Antigens, CD34/biosynthesis Bone Marrow/metabolism Breast Neoplasms/blood supply Disease Models, Animal Endothelial Growth Factors/genetics,metabolism Endothelium, Vascular/metabolism,pathology Enzyme-Linked Immunosorbent Assay Female Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology Humans In Vitro Techniques Intercellular Signaling Peptides and Proteins/genetics,metabolism Interleukin-8/metabolism Lipoproteins, LDL/metabolism Lymphokines/genetics,metabolism Mice Mice, Inbred BALB C Mice, Nude Neoplasm Transplantation Neovascularization, Pathologic/metabolism,pathology Receptors, Vascular Endothelial Growth Factor/metabolism Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factor Receptor-2/metabolism Vascular Endothelial Growth Factors
Chemicals
Antigens, CD34 Endothelial Growth Factors Intercellular Signaling Peptides and Proteins Interleukin-8 Lipoproteins, LDL Lymphokines Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors Granulocyte-Macrophage Colony-Stimulating Factor Receptors, Vascular Endothelial Growth Factor Vascular Endothelial Growth Factor Receptor-2
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Shirakawa K
Pharmacology Division, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-Ku, Tokyo 104-0045, Japan. [email protected]
Furuhata S
Watanabe I
Hayase H
Shimizu A
Ikarashi Y
Yoshida T
Terada M
Hashimoto D
Wakasugi H
References (21)
21 references, click to expand
  1. Clinical applications of angiogenic growth factors and their inhibitors.
    Nat Med. 1999 Dec;5(12):1359-64 PMID: 10581076
  2. In vivo assessment of vascular endothelial growth factor-induced angiogenesis.
    Int J Cancer. 1999 Dec 10;83(6):798-802 PMID: 10597197
  3. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.
    Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3422-7 PMID: 10725398
  4. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization.
    J Clin Invest. 2000 Jun;105(11):1527-36 PMID: 10841511
  5. Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes.
    Gene Ther. 2000 Jun;7(12):1027-33 PMID: 10871751
  6. Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer.
    Cancer Res. 2001 Jan 15;61(2):445-51 PMID: 11212228
  7. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.
    J Exp Med. 2001 May 7;193(9):1005-14 PMID: 11342585
  8. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
    Cancer Res. 2001 Oct 15;61(20):7654-9 PMID: 11606408
  9. Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer.
    Int J Cancer. 2002 May 20;99(3):344-51 PMID: 11992402
  10. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.
    Nature. 2002 Jun 27;417(6892):954-8 PMID: 12087404
  11. Angiogenic factors.
    Science. 1987 Jan 23;235(4787):442-7 PMID: 2432664
  12. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.
    Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10705-9 PMID: 8248162
  13. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.
    Cell. 1997 Jan 24;88(2):277-85 PMID: 9008168
  14. Isolation of putative progenitor endothelial cells for angiogenesis.
    Science. 1997 Feb 14;275(5302):964-7 PMID: 9020076
  15. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition).
    Br J Cancer. 1998;77(1):1-10 PMID: 9459138
  16. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate.
    Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8795-800 PMID: 9671758
  17. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
    Cancer Res. 1998 Aug 1;58(15):3362-9 PMID: 9699667
  18. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.
    Nat Med. 1999 Apr;5(4):434-8 PMID: 10202935
  19. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.
    J Clin Invest. 1999 May;103(9):1231-6 PMID: 10225965
  20. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.
    Science. 1999 Jun 18;284(5422):1994-8 PMID: 10373119
  21. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells.
    EMBO J. 1999 Jul 15;18(14):3964-72 PMID: 10406801
Article Info
Journal
British journal of cancer
Abbr.
Br J Cancer
ISSN
0007-0920
Published
2002-12-02
Pages
1454-61
Language
English
Region
England
NLM ID
0370635
PMCID
PMC2376301
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]